UBS Group’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
– Sell
-100
Closed -$7K – 10515
2014
Q2
$7K Sell
100
-40
-29% -$3.09K ﹤0.01% 9220
2014
Q1
$12K Hold
140
– – ﹤0.01% 8685
2013
Q4
$11K Sell
140
-20
-13% -$1.63K ﹤0.01% 8877
2013
Q3
$14K Buy
160
+60
+60% +$5.49K ﹤0.01% 8466
2013
Q2
$9K Hold
100
– – ﹤0.01% 8730

Other funds holding HHS

UBS Group's HHS Position: Q3 2026 in Review

UBS Group increased its Harte-Hanks (HHS) stake by 104% in Q3 2026, buying an estimated $539 and bringing the position to 310 shares worth $1.41K. The position accounts for ﹤0.01% of the portfolio, ranked #10264.

UBS Group first reported a position in HHS in Q2 2013 and has held it in 39 quarters since. The position peaked at $193K in Q2 2025. 31 funds tracked by Wall St. Rank hold HHS as of Q3 2026.

  • UBS Group held 310 shares of Harte-Hanks worth $1.41K as of Q3 2026.
  • UBS Group bought 158 Harte-Hanks shares in Q3 2026, an estimated $539.
  • Harte-Hanks made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #10264 holding.
  • UBS Group first reported a position in Harte-Hanks in Q2 2013 and has held it in 39 quarters since.
  • UBS Group's Harte-Hanks position peaked at $193K in Q2 2025.
  • 31 funds tracked by Wall St. Rank held Harte-Hanks as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.